LORACARBEF ANHYDROUS

SynDRA canonical compound SYN0003124 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · OTC
Mechanism of action	bacterial cell wall synthesis inhibitor
Indication	bronchitis \| ear infections \| laryngitis \| pneumonia \| skin infections \| urinary tract infections
Disease area	infectious disease \| otolaryngology \| pulmonary

All known targets

loracarbef
lorabid
loribid
loracarbef hydrate
Anhydrous loracarbef
Loracarbef, anhydrous
Lorbef
LY-163892
Loracarbef
Lorabid
Loracarbefum
Lorafem
Loracarbef hydrate
KT-3777
Lorabid (TN)
(6R,7S)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate
(6R,7S)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7S)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate
(6R,7S)-7-{[(2R)-2-ammonio-2-phenylacetyl]amino}-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
7beta-[(2R)-2-amino-2-phenylacetyl]nitrilo-3-chloro-3,4-didehydrocepham-4-carboxylate
7beta-[(2R)-2-amino-2-phenylacetyl]nitrilo-3-chloro-3,4-didehydrocepham-4-carboxylic acid
7beta-[(2R)-2-ammonio-2-phenylacetyl]nitrilo-3-chloro-3,4-didehydrocepham-4-carboxylate
LORACARBEF
LORACARBEF, ANHYDROUS
KT 3777
W72I5ZT78Z
LY163892
LY 163892
CHEBI:47544
RefChem:800042
DTXCID503223
J01DA38
3X11EVM5SU
LY 163892 monohydrate
LY163892 MONOHYDRATE
Loracarbefum [INN-Latin]